Celso Arango López (Palma de Mallorca, 1968) es un psiquiatra español. Desarrolla su labor en la investigación, la docencia y la clínica, especialmente en el campo de la psiquiatría infanto-juvenil y las psicosis.
Fusar Poli et al. The lived experience of mental disorders in adolescents: a bottom-up review co-designed, co-conducted and co-written by experts by experience and academics. World Psychiatry. 2024 Jun;23(2):191-208.
Arango et al. Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries. Lancet Psychiatry. 2022 Feb;9(2):113-124.
Arango et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021 Oct;20(3):417-436.
Arango et al. Preventive strategies for mental health. Lancet Psychiatry. 2018 Jul;5(7):591-604.
Lim et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nature Neuroscience. 2017 Sep;20(9):1217-1224
Galling et al. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2016 Mar;73(3):247-59.
Vorstman JA, et al. Deletion Syndrome. Cognitive Decline Preceding the Onset of Psychosis in Patients with 22q11.2 Deletion Syndrome. JAMA Psychiatry. 2015 Apr;72(4):377-85.
Steinberg S, et al. Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry. 2014 Jan;19(1):108-14.
Arango C. Child neuropsychopharmacology: good news… the glass is half full. World Psychiatry. 2013 Jun;12(2):128-9.
Arango C et al. Progressive brain changes in children and adolescents with first-episode psychosis. JAMA Psychiatry. 2012 Jan; 69(1):16-26.
Steinberg S et al. Common Variants at VRK2 and TCF4 Conferring Risk of Schizophrenia. Hum Mol Genet. 2011 Oct; 20(20):4076-81.
.svg){kind=small}
